Ian Karp
Public Communications Contact presso INTELLIA THERAPEUTICS, INC.
Profilo
Ian Karp is currently the Senior Vice President-Corporate Communications at Intellia Therapeutics, Inc. He previously worked as the Senior Director-Global Marketing at Medimmune, Inc. and as the Vice President & Head-Investor Relations at Shire Plc.
He also served as the Senior Vice President-Investor & Public Relations at Karyopharm Therapeutics, Inc. Mr. Karp received his undergraduate degree from Emory University and his MBA from Rutgers Business School.
Posizioni attive di Ian Karp
| Società | Posizione | Inizio |
|---|---|---|
| INTELLIA THERAPEUTICS, INC. | Public Communications Contact | - |
Precedenti posizioni note di Ian Karp
| Società | Posizione | Fine |
|---|---|---|
| SHIRE | Contatto Relazioni con gli Investitori | 01/12/2017 |
| Medimmune, Inc. | Vendite & Marketing | - |
| KARYOPHARM THERAPEUTICS INC. | Contatto Relazioni con gli Investitori | - |
Formazione di Ian Karp
| Emory University | Undergraduate Degree |
| Rutgers Business School | Masters Business Admin |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| INTELLIA THERAPEUTICS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
| Medimmune, Inc. | Health Technology |
- Borsa valori
- Insiders
- Ian Karp
